Benzodiazepine Drug Class: Drug Safety Communication - Boxed Warning Updated to Improve Safe Use
Date of publication: 23-09-2020
The FDA is requiring the Boxed Warning be updated by adding other information to the prescribing information for all benzodiazepine medicines. This information will describe the risks of abuse, misuse, addiction, physical dependence, and withdrawal reactions across all the medicines in the class. Źródło: http://www.fda.gov
